These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 4607729

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS.
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Use of plasma levels in evaluation of procainamide dosage.
    Shaw TR, Kumana CR, Royds RB, Padgham CM, Hamer J.
    Br Heart J; 1974 Mar; 36(3):265-70. PubMed ID: 4132893
    [No Abstract] [Full Text] [Related]

  • 27. Lidocaine and procainamide toxicity during treatment of ventricular arrhythmias.
    Mattea J, Mattea E.
    Am J Nurs; 1976 Sep; 76(9):1429-31. PubMed ID: 1048862
    [No Abstract] [Full Text] [Related]

  • 28. [Treatment of arrhythmias].
    Radzivil VF, Fedyshin PS, Furkalo NK, Korkushko OV.
    Vrach Delo; 1967 May; 5():54-7. PubMed ID: 5618542
    [No Abstract] [Full Text] [Related]

  • 29. Arrhythmias in myocardial infarction.
    DeSanctis RW.
    Del Med J; 1971 Aug; 43(8):209-15. PubMed ID: 5094607
    [No Abstract] [Full Text] [Related]

  • 30. [Clinical experience in the use of bupivacaine as an anti-arrhythmia agent].
    Sakio H, Yoshida Y, Shimamura K.
    Masui; 1973 Oct; 22(11):1298-302. PubMed ID: 4797359
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide].
    Savina MD, Kudrin AN.
    Farmakol Toksikol; 1982 Oct; 45(2):63-5. PubMed ID: 7075754
    [No Abstract] [Full Text] [Related]

  • 37. Experiences on a sustained-release procainamide preparation.
    Ruosteenoja R, Torsti P, Sothmann A.
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):707-12. PubMed ID: 4201315
    [No Abstract] [Full Text] [Related]

  • 38. Drug therapy today: latest strategies for post-MI dysrhythmias.
    Rodman MJ.
    RN; 1981 Feb; 44(2):63-8. PubMed ID: 6906872
    [No Abstract] [Full Text] [Related]

  • 39. Safety and efficacy of procainamide infusions.
    Lima JJ, Goldfarb AL, Conti DR, Golden LH, Bascomb BL, Benedetti GM, Jusko WJ.
    Am J Cardiol; 1979 Jan; 43(1):98-105. PubMed ID: 758776
    [Abstract] [Full Text] [Related]

  • 40. Prophylaxis of dysrhythmias after myocardial infarction.
    Br Med J; 1970 Mar 14; 1(5697):646. PubMed ID: 5443964
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.